<html>
<head>
  <title>CodeSystem-sectionType-html</title>
  <link rel="stylesheet" href="fhir.css"/>
</head>
<body>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system https://www.hl7.org/fhir/us-pq-cmc/CodeSystem/sectionType defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">32S10<a name="sectionType-32S10"> </a></td><td>Substance General Information</td></tr><tr><td style="white-space:nowrap">32S11<a name="sectionType-32S11"> </a></td><td>Substance Nomenclature</td></tr><tr><td style="white-space:nowrap">32S12<a name="sectionType-32S12"> </a></td><td>Substance Structure</td></tr><tr><td style="white-space:nowrap">32S13<a name="sectionType-32S13"> </a></td><td>Substance General Properties</td></tr><tr><td style="white-space:nowrap">32S20<a name="sectionType-32S20"> </a></td><td>Substance Manufacture</td></tr><tr><td style="white-space:nowrap">32S21<a name="sectionType-32S21"> </a></td><td>Substance Manufacturers</td></tr><tr><td style="white-space:nowrap">32S22<a name="sectionType-32S22"> </a></td><td>Substance Description of Manufacturing Process and Process Controls</td></tr><tr><td style="white-space:nowrap">32S23<a name="sectionType-32S23"> </a></td><td>Substance Control of Materials</td></tr><tr><td style="white-space:nowrap">32S24<a name="sectionType-32S24"> </a></td><td>Substance Controls of Critical Steps and Intermediates</td></tr><tr><td style="white-space:nowrap">32S25<a name="sectionType-32S25"> </a></td><td>Substance Process Validation and/or Evaluation</td></tr><tr><td style="white-space:nowrap">32S26<a name="sectionType-32S26"> </a></td><td>Substance Manufacturing Process Development</td></tr><tr><td style="white-space:nowrap">32S30<a name="sectionType-32S30"> </a></td><td>Substance Characterization</td></tr><tr><td style="white-space:nowrap">32S31<a name="sectionType-32S31"> </a></td><td>Substance Elucidation of Structure and other Characteristics</td></tr><tr><td style="white-space:nowrap">32S32<a name="sectionType-32S32"> </a></td><td>Substance Impurities</td></tr><tr><td style="white-space:nowrap">32S40<a name="sectionType-32S40"> </a></td><td>Substance Control of Drug Substance</td></tr><tr><td style="white-space:nowrap">32S41<a name="sectionType-32S41"> </a></td><td>Substance Specification</td></tr><tr><td style="white-space:nowrap">32S42<a name="sectionType-32S42"> </a></td><td>Substance Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32S43<a name="sectionType-32S43"> </a></td><td>Substance Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32S44<a name="sectionType-32S44"> </a></td><td>Substance Batch Analyses</td></tr><tr><td style="white-space:nowrap">32S45<a name="sectionType-32S45"> </a></td><td>Substance Justification of Specification</td></tr><tr><td style="white-space:nowrap">32S50<a name="sectionType-32S50"> </a></td><td>Substance Reference Standards or Materials</td></tr><tr><td style="white-space:nowrap">32S60<a name="sectionType-32S60"> </a></td><td>Substance Container Closure System</td></tr><tr><td style="white-space:nowrap">32S70<a name="sectionType-32S70"> </a></td><td>Substance Stability</td></tr><tr><td style="white-space:nowrap">32S71<a name="sectionType-32S71"> </a></td><td>Substance Stability Summary and Conclusions</td></tr><tr><td style="white-space:nowrap">32S72<a name="sectionType-32S72"> </a></td><td>Substance Postapproval Stability Protocol and Stability Commitment</td></tr><tr><td style="white-space:nowrap">32S73<a name="sectionType-32S73"> </a></td><td>Substance Stability Data</td></tr><tr><td style="white-space:nowrap">32P10<a name="sectionType-32P10"> </a></td><td>Product Description and Composition of the Drug Product</td></tr><tr><td style="white-space:nowrap">32P20<a name="sectionType-32P20"> </a></td><td>Product Pharmaceutical Development</td></tr><tr><td style="white-space:nowrap">32P21<a name="sectionType-32P21"> </a></td><td>Product Components of the Drug Product</td></tr><tr><td style="white-space:nowrap">32P22<a name="sectionType-32P22"> </a></td><td>Product Drug Product</td></tr><tr><td style="white-space:nowrap">32P23<a name="sectionType-32P23"> </a></td><td>Product Manufacturing Process Development</td></tr><tr><td style="white-space:nowrap">32P24<a name="sectionType-32P24"> </a></td><td>Product Container Closure System</td></tr><tr><td style="white-space:nowrap">32P25<a name="sectionType-32P25"> </a></td><td>Product Microbiological Attributes</td></tr><tr><td style="white-space:nowrap">32P26<a name="sectionType-32P26"> </a></td><td>Product Compatibility</td></tr><tr><td style="white-space:nowrap">32P30<a name="sectionType-32P30"> </a></td><td>Product Manufacture</td></tr><tr><td style="white-space:nowrap">32P31<a name="sectionType-32P31"> </a></td><td>Product Manufacturers</td></tr><tr><td style="white-space:nowrap">32P32<a name="sectionType-32P32"> </a></td><td>Product Batch Formula</td></tr><tr><td style="white-space:nowrap">32P33<a name="sectionType-32P33"> </a></td><td>Product Description of Manufacturing Process and Process Controls</td></tr><tr><td style="white-space:nowrap">32P34<a name="sectionType-32P34"> </a></td><td>Product Controls of Critical Steps and Intermediates</td></tr><tr><td style="white-space:nowrap">32P35<a name="sectionType-32P35"> </a></td><td>Product Process Validation and/or Evaluation</td></tr><tr><td style="white-space:nowrap">32P40<a name="sectionType-32P40"> </a></td><td>Product Control of Excipients</td></tr><tr><td style="white-space:nowrap">32P41<a name="sectionType-32P41"> </a></td><td>Excipients Specifications</td></tr><tr><td style="white-space:nowrap">32P42<a name="sectionType-32P42"> </a></td><td>Product Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P43<a name="sectionType-32P43"> </a></td><td>Product Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P44<a name="sectionType-32P44"> </a></td><td>Product Justification of Specifications</td></tr><tr><td style="white-space:nowrap">32P45<a name="sectionType-32P45"> </a></td><td>Product Excipients of Human or Animal Origin</td></tr><tr><td style="white-space:nowrap">32P46<a name="sectionType-32P46"> </a></td><td>Product Novel Excipients</td></tr><tr><td style="white-space:nowrap">32P50<a name="sectionType-32P50"> </a></td><td>Product name - dosage form</td></tr><tr><td style="white-space:nowrap">32P51<a name="sectionType-32P51"> </a></td><td>Product Specifications</td></tr><tr><td style="white-space:nowrap">32P52<a name="sectionType-32P52"> </a></td><td>Product Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P53<a name="sectionType-32P53"> </a></td><td>Product Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P54<a name="sectionType-32P54"> </a></td><td>Product Batch Analyses</td></tr><tr><td style="white-space:nowrap">32P55<a name="sectionType-32P55"> </a></td><td>Product Characterization of Impurities</td></tr><tr><td style="white-space:nowrap">32P56<a name="sectionType-32P56"> </a></td><td>Product Justification of Specifications</td></tr><tr><td style="white-space:nowrap">32P60<a name="sectionType-32P60"> </a></td><td>Product Reference Standards or Materials</td></tr><tr><td style="white-space:nowrap">32P70<a name="sectionType-32P70"> </a></td><td>Product Container Closure System</td></tr><tr><td style="white-space:nowrap">32P80<a name="sectionType-32P80"> </a></td><td>Product Stability</td></tr><tr><td style="white-space:nowrap">32P81<a name="sectionType-32P81"> </a></td><td>Product Stability Summary and Conclusion</td></tr><tr><td style="white-space:nowrap">32P82<a name="sectionType-32P82"> </a></td><td>Product Postapproval Stability Protocol and Stability Commitment</td></tr><tr><td style="white-space:nowrap">32P83<a name="sectionType-32P83"> </a></td><td>Product Stability Data</td></tr><tr><td style="white-space:nowrap">SP4151<a name="sectionType-SP4151"> </a></td><td>Quality Specification</td></tr></table></div></body>
</html>
